BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34047469)

  • 1. Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.
    Wang J; Wang C; Li Y; Li M; Zhu T; Shen Z; Wang H; Lv W; Wang X; Cheng X; Xie X
    Clin Transl Med; 2021 May; 11(5):e425. PubMed ID: 34047469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
    Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
    Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p/TRIM44 axis.
    Ye H; Wang RY; Yu XZ; Wu YK; Yang BW; Ao MY; Xi MR; Hou MM
    Kaohsiung J Med Sci; 2023 Jan; 39(1):26-39. PubMed ID: 36448712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p.
    Chen S; Chen X; Luo Q; Liu X; Wang X; Cui Z; He A; He S; Jiang Z; Wu N; Chen P; Yu K; Zhuang J
    Cell Death Dis; 2021 Jul; 12(7):695. PubMed ID: 34257272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer.
    Zhan R; Yu H; Zhang G; Ding Q; Li H; Li X; Tang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):189. PubMed ID: 38812317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNA-23b-3p promotes tumor angiogenesis and metastasis by targeting PTEN in salivary adenoid cystic carcinoma.
    Hou CX; Sun NN; Han W; Meng Y; Wang CX; Zhu QH; Tang YT; Ye JH
    Carcinogenesis; 2022 Aug; 43(7):682-692. PubMed ID: 35380635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1.
    Liu Z; Du D; Zhang S
    Cancer Biol Ther; 2024 Dec; 25(1):2290033. PubMed ID: 38073044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure.
    Qu Q; Liu L; Cui Y; Liu H; Yi J; Bing W; Liu C; Jiang D; Bi Y
    Stem Cell Res Ther; 2022 Jul; 13(1):352. PubMed ID: 35883161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placenta mesenchymal stem cell-derived exosome shuttling microRNA-130b-3p from gestational diabetes mellitus patients targets ICAM-1 and perturbs human umbilical vein endothelial cell angiogenesis.
    Gao Z; Wang N; Liu X
    Acta Diabetol; 2022 Aug; 59(8):1091-1107. PubMed ID: 35676597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis.
    Qiu S; Xie L; Lu C; Gu C; Xia Y; Lv J; Xuan Z; Fang L; Yang J; Zhang L; Li Z; Wang W; Xu H; Li B; Xu Z
    J Exp Clin Cancer Res; 2022 Oct; 41(1):296. PubMed ID: 36217165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Exosomal miR-144-3p from Crohn's Disease Patients Inhibits Human Umbilical Vein Endothelial Cell Function by Targeting
    Qu P; Xie X; Chi J; Liu X; Liu P; Luo J; Li H; Cheng S; Xia X; Chen X; Xu C
    Dis Markers; 2022; 2022():8219557. PubMed ID: 35692876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
    Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
    Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.
    Zhao Z; Shuang T; Gao Y; Lu F; Zhang J; He W; Qu L; Chen B; Hao Q
    Cancer Lett; 2022 Apr; 530():45-58. PubMed ID: 35051533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis.
    Ghaffari-Makhmalbaf P; Sayyad M; Pakravan K; Razmara E; Bitaraf A; Bakhshinejad B; Goudarzi P; Yousefi H; Pournaghshband M; Nemati F; Fahimi H; Rohollah F; Hasanzad M; Hashemi M; Mousavi SH; Babashah S
    Life Sci; 2021 Jan; 264():118719. PubMed ID: 33159957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes derived from stem cells of human deciduous exfoliated teeth inhibit angiogenesis in vivo and in vitro via the transfer of miR-100-5p and miR-1246.
    Liu P; Zhang Q; Mi J; Wang S; Xu Q; Zhuang D; Chen W; Liu C; Zhang L; Guo J; Wu X
    Stem Cell Res Ther; 2022 Mar; 13(1):89. PubMed ID: 35241153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
    Chen X; Mangala LS; Mooberry L; Bayraktar E; Dasari SK; Ma S; Ivan C; Court KA; Rodriguez-Aguayo C; Bayraktar R; Raut S; Sabnis N; Kong X; Yang X; Lopez-Berestein G; Lacko AG; Sood AK
    Oncogene; 2019 Aug; 38(33):6095-6108. PubMed ID: 31289363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
    Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of total coumarins from
    Liu Y; Cheng DH; Su ZY; Lv JH; Wang L; Deng YY; Li L
    Pharm Biol; 2024 Dec; 62(1):153-161. PubMed ID: 38347502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer.
    Kobayashi M; Sawada K; Miyamoto M; Shimizu A; Yamamoto M; Kinose Y; Nakamura K; Kawano M; Kodama M; Hashimoto K; Kimura T
    Biochem Biophys Res Commun; 2020 Jun; 527(1):153-161. PubMed ID: 32446360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.